Biggest News Aggregation in the World
📰 Michael Erman News

Page 97 - Michael Erman News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Michael Erman. Real-time updates on events, politics, business and more.

J&J COVID-19 vaccine on track for March rollout, still aims for 1 billion doses this year - executive

CHICAGO (Reuters) - Johnson & Johnson is on track to roll out its single-shot coronavirus vaccine in March, and expects to have clear data on how effective it is by the end of this month or early February, the U.S. healthcare company's chief scientific officer said.
New York United States South Africa Moncef Slaoui Paul Stoffels Julie Steenhuysen

Pfizer has produced more than 70 million COVID-19 vaccine doses: CEO

<div class="at-above-post addthis_tool" data-url="https://www.metro.us/pfizer-has-produced-more/"></div>NEW YORK (Reuters) – Pfizer Inc and German partner BioNTech SE had produced over 70 million doses of their COVID-19 vaccine by the end of 2020, Chief Executive Albert Bourla said in an interview on CNBC on Tuesday. “At the end of the last week of 2020, for example, we had already manufactured more than […]<!-- AddThis Advanced Settings abov...
Albert Bourla Pfizer Inc Chief Executive Albert Bourla Michael Erman ஃபைசர் இன்க் மைக்கேல் அர்மந்
Source: metro.us

Bristol Myers sees up to $25 billion a year of new revenue from current drug pipeline

By Reuters Staff 2 Min Read NEW YORK (Reuters) - Bristol Myers Squibb said on Monday that its current drug pipeline has the ability to replace up to $25 billion a year in lost revenue from patent expirations by the end of the decade. According to a presentation for JP Morgan’s annual healthcare conference, the company said anemia drug Reblozyl, as well as experimental heart drug mavacamten, psoriasis drug deucravacitinib and its cancer cell therapy franchise could each be responsible for more...
Chris Boerner Bristol Myers Thomson Reuters Trust Principles Myokardia Inc Jp Morgan York Stock Exchange On

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Pfizer/BioNTech vaccine works against virus variants in lab; arthritis drugs improve COVID-19 survival

6 Min Read (Reuters) -The following is a roundup of some of the latest scientific studies on the novel coronavirus and efforts to find treatments and vaccines for COVID-19, the illness caused by the virus. FILE PHOTO: The ultrastructural morphology exhibited by the 2019 Novel Coronavirus (2019-nCoV), is seen in an illustration released by the Centers for Disease Control and Prevention (CDC) in Atlanta, Georgia, U.S. January 29, 2020. Alissa Eckert, MS; Dan Higgins, MAM/CDC/Handout via REUTERS....
City Of United Kingdom South Africa Phil Dormitzer Anthony Gordon Nancy Lapid

COVID SCIENCE-Pfizer/BioNTech vaccine works against virus variants in lab; arthritis drugs improve COVID-19 survival

6 Min Read (Reuters) -The following is a roundup of some of the latest scientific studies on the novel coronavirus and efforts to find treatments and vaccines for COVID-19, the illness caused by the virus. FILE PHOTO: The ultrastructural morphology exhibited by the 2019 Novel Coronavirus (2019-nCoV), is seen in an illustration released by the Centers for Disease Control and Prevention (CDC) in Atlanta, Georgia, U.S. January 29, 2020. Alissa Eckert, MS; Dan Higgins, MAM/CDC/Handout via REUTERS....
City Of United Kingdom South Africa Phil Dormitzer Anthony Gordon Nancy Lapid

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science